BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23188220)

  • 1. α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.
    Lee YH; Hsu CY; Huang YH; Su CW; Lin HC; Hsia CY; Huo TI
    J Gastrointest Surg; 2013 Apr; 17(4):730-8. PubMed ID: 23188220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
    Sun LY; Cen WJ; Zeng XX; Zhong YY; Deng L; Yang JJ; Li M; Wang F
    Am Surg; 2024 Jun; 90(6):1240-1249. PubMed ID: 38214585
    [TBL] [Abstract][Full Text] [Related]  

  • 3.  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.
    Sarkar M; Dodge JL; Roberts JP; Terrault N; Yao F; Mehta N
    Ann Hepatol; 2016; 15(4):545-9. PubMed ID: 27236153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data.
    Li B; Liu A; Wen Y; Yang G; Zhao J; Li X; Mao Y; Li B
    J Clin Lab Anal; 2021 Sep; 35(9):e23932. PubMed ID: 34403527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment.
    Mazza S; Frigerio C; Alfieri D; Mauro A; Torello Viera F; Scalvini D; Barteselli C; Sgarlata C; Veronese L; Bardone M; Rovedatti L; Agazzi S; Strada E; Pozzi L; Maestri M; Ravetta V; Anderloni A
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792876
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor Volume.
    Shih HW; Lai Y; Hung HC; Lee JC; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC; Cheng CH
    Dig Dis Sci; 2024 Jun; ():. PubMed ID: 38824258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study.
    Brandão ABM; Rodriguez S; Marroni CA; Junior AMF; Fernandes MV; Mucenic M
    Ann Hepatol; 2024; 29(2):101184. PubMed ID: 38008358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival prediction of hepatocellular carcinoma by measuring the extracellular volume fraction with single-phase contrast-enhanced dual-energy CT imaging.
    Chen Y; Shi K; Li Z; Wang H; Liu N; Zhan P; Liu X; Shang B; Hou P; Gao J; Lyu P
    Front Oncol; 2023; 13():1199426. PubMed ID: 37538109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
    Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
    Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
    Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
    Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection.
    Xu Y; Yao X; Li J; Zhang G; Luo G; Wang Q
    Cancer Med; 2023 Jun; 12(12):13329-13341. PubMed ID: 37165912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion.
    Zhang N; Wang Z; Lv J; Zhang S; Liu Y; Liu T; Li W; Gong L; Zhang X; El-Omar EM; Lu W
    Front Med (Lausanne); 2022; 9():836369. PubMed ID: 35372388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.
    Zakaria HM; Mohamed A; Omar H; Gaballa NK
    Ann Med Surg (Lond); 2020 Jun; 54():109-113. PubMed ID: 32426129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.
    Zakaria HM; Macshut M; Gaballa NK; Sherif AE; Abdel-Samea ME; Abdel-Samiee M; Marwan I; Yassein T
    Ann Med Surg (Lond); 2020 Jun; 54():47-53. PubMed ID: 32368340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Score Predicts HBV-Related Hepatocellular Carcinoma Recurrence After Hepatectomy: a Retrospective Multicenter Study.
    Qin W; Wang L; Hu B; Leng S; Tian H; Luo H; Yao J; Chen X; Wu C; Chen G; Yang Y
    J Gastrointest Surg; 2019 May; 23(5):922-932. PubMed ID: 30446938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.
    Hsu CY; Liu PH; Ho SY; Hsia CY; Kudaravalli P; Lee YH; Chiou YY; Tsai YJ; Huang YH; Huo TI
    BMC Cancer; 2018 Mar; 18(1):289. PubMed ID: 29540157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for hepatocellular carcinoma: What is missing?
    Mehta NJ; Celik AD; Peters MG
    Hepatol Commun; 2017 Feb; 1(1):18-22. PubMed ID: 29404430
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.